CA2395240A1 - Marqueurs bialleles derives de regions genomiques comportant des genes responsables de troubles du systeme nerveux central - Google Patents
Marqueurs bialleles derives de regions genomiques comportant des genes responsables de troubles du systeme nerveux central Download PDFInfo
- Publication number
- CA2395240A1 CA2395240A1 CA002395240A CA2395240A CA2395240A1 CA 2395240 A1 CA2395240 A1 CA 2395240A1 CA 002395240 A CA002395240 A CA 002395240A CA 2395240 A CA2395240 A CA 2395240A CA 2395240 A1 CA2395240 A1 CA 2395240A1
- Authority
- CA
- Canada
- Prior art keywords
- biallelic marker
- cns disorder
- sequence
- polynucleotide
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17585400P | 2000-01-13 | 2000-01-13 | |
US60/175,854 | 2000-01-13 | ||
PCT/IB2001/000116 WO2001051659A2 (fr) | 2000-01-13 | 2001-01-11 | Marqueurs bialleles derives de regions genomiques comportant des genes responsables de troubles du systeme nerveux central |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2395240A1 true CA2395240A1 (fr) | 2001-07-19 |
Family
ID=22641928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002395240A Abandoned CA2395240A1 (fr) | 2000-01-13 | 2001-01-11 | Marqueurs bialleles derives de regions genomiques comportant des genes responsables de troubles du systeme nerveux central |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1285088A2 (fr) |
AU (1) | AU2699901A (fr) |
CA (1) | CA2395240A1 (fr) |
WO (1) | WO2001051659A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7119085B2 (en) | 2000-03-23 | 2006-10-10 | Elan Pharmaceuticals, Inc. | Methods to treat alzheimer's disease |
AU2003222965A1 (en) * | 2002-04-05 | 2003-10-27 | University Court Of The University Of Edinburgh | Schizophrenia associated genes |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
US7927840B2 (en) | 2006-09-11 | 2011-04-19 | Gen Probe Incorporated | Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region |
CA2501946C (fr) | 2002-10-16 | 2014-12-23 | Gen-Probe Incorporated | Compositions et methodes de detection du virus du nil occidental |
US20090291432A1 (en) * | 2004-06-01 | 2009-11-26 | Queensland University Of Technology | Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene |
US20090221670A1 (en) * | 2005-05-11 | 2009-09-03 | Aarhus Universitet | Method for diagnosis and treatment of a mental disease |
KR100818275B1 (ko) * | 2006-09-26 | 2008-03-31 | 삼성전자주식회사 | 노로바이러스의 표적 서열을 증폭하기 위한 프라이머 세트,노로바이러스의 표적 서열에 특이적으로 혼성화하는프로브 세트, 상기 프로브 세트가 고정화되어 있는마이크로어레이 및 상기 프로브 세트를 이용하여노로바이러스의 존재를 검출하는 방법 |
US20090075827A1 (en) * | 2007-01-19 | 2009-03-19 | Queensland University Of Technology | Diagnostic methods and agents |
ES2702619T3 (es) * | 2013-04-22 | 2019-03-04 | Innobioscience Llc | Tratamiento de la enfermedad de Alzheimer y deterioro cognitivo con andrografólidos |
CA2991894A1 (fr) * | 2015-07-10 | 2017-01-19 | Ionis Pharmaceuticals, Inc. | Modulateurs de diacylglycerol acyltransferase 2 (dgat2) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1071817A2 (fr) * | 1998-04-21 | 2001-01-31 | Genset | Marqueurs bialleles convenant a la constitution d'une carte haute densite des desequilibres du genome humain |
-
2001
- 2001-01-11 AU AU26999/01A patent/AU2699901A/en not_active Abandoned
- 2001-01-11 EP EP01901330A patent/EP1285088A2/fr not_active Withdrawn
- 2001-01-11 CA CA002395240A patent/CA2395240A1/fr not_active Abandoned
- 2001-01-11 WO PCT/IB2001/000116 patent/WO2001051659A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001051659A3 (fr) | 2002-12-05 |
WO2001051659A2 (fr) | 2001-07-19 |
EP1285088A2 (fr) | 2003-02-26 |
AU2699901A (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6525185B1 (en) | Polymorphisms associated with hypertension | |
US20040254363A1 (en) | Genes and snps associated with eating disorders | |
CA2395240A1 (fr) | Marqueurs bialleles derives de regions genomiques comportant des genes responsables de troubles du systeme nerveux central | |
US20110236896A1 (en) | Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication | |
CA2324866A1 (fr) | Marqueurs bialleles convenant a la constitution d'une carte haute densite des desequilibres du genome humain | |
US20050233321A1 (en) | Identification of novel polymorphic sites in the human mglur8 gene and uses thereof | |
KR101141185B1 (ko) | 치료의 제안된 효능 검출용 마커 | |
WO2001048245A2 (fr) | Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants | |
US20060234221A1 (en) | Biallelic markers of d-amino acid oxidase and uses thereof | |
US20040180370A1 (en) | Genetic diagnosis of alcoholism subtypes | |
US20030170667A1 (en) | Single nucleotide polymorphisms diagnostic for schizophrenia | |
US20030082537A1 (en) | Methods for genetic analysis of DNA to detect sequence variances | |
US20030224365A1 (en) | Single nucleotide polymorphisms diagnostic for schizophrenia | |
US20040115699A1 (en) | Single nucleotide polymorphisms diagnostic for schizophrenia | |
US20030170679A1 (en) | Single nucleotide polymorphisms in GH-1 | |
US20040235041A1 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
EP1100962A1 (fr) | Polymorphismes genetiques du gene du recepteur neurokininique 1 de l'homme et leurs utilisations pour le diagnostic et le traitement d'affections | |
EP1546398A4 (fr) | Diagnostic unique des polymorphismes nucleotidiques predestinant a la schizophrenie | |
CA2427214A1 (fr) | Procedes d'evaluation du risque de diabete sucre non insulino-dependant sur la base de variations alleliques dans la zone marginale 5' du gene de l'insuline et des tissus adipeux | |
AU2002338451A1 (en) | Single nucleotide polymorphisms diagnostic for schizophrenia | |
JP2005524383A (ja) | 統合失調症の診断に用いる一塩基多型 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |